Tokyo, Nov. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059565) titled 'Verification study on anti-fatigue housing environment' on Nov. 17.

Study Type: Interventional

Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Open -no one is blinded Control - Placebo

Primary Sponsor: Institute - Osaka Metropolitan University

Condition: Condition - Healthy person Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Evaluation for effects of recovery from fatigue in a house focusing window configuration. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - After fatigue-inducing tasks, rest in a space with an outdoor view. Interventions/Control_2 - After fatigue-inducing tasks, rest in a space without an outdoor view.

Eligibility: Age-lower limit - 20 years-old = Gender - Male and Female Key inclusion criteria - 1.Individuals aged 20 to 65 years who do not meet the exclusion criteria. 2.Individuals who understand the contents of the informed consent explanation and can provide written consent voluntarily. Key exclusion criteria - 1.Individuals with a history of serious diseases related to the brain, nervous system, cardiovascular system, or other severe conditions, or those currently undergoing treatment, including those taking prescribed medication. 2.Individuals with a history of seizures (such as loss of consciousness, coma, convulsions, etc.). 3.Individuals with hearing or vision impairments that make it difficult to complete the essential evaluation items of this study. 4.Individuals who are currently pregnant or breastfeeding. 5.Individuals currently participating in another clinical trial or who have participated in another interventional clinical trial within one month prior to obtaining consent. 6. Individuals deemed unsuitable by the principal investigator. Target Size - 32

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 08 Month 19 Day Date of IRB - 2025 Year 08 Month 26 Day Anticipated trial start date - 2025 Year 11 Month 18 Day Last follow-up date - 2025 Year 12 Month 10 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068129

Disclaimer: Curated by HT Syndication.